TITsutomu Itagaki

Tsutomu Itagaki

*This is an algorithmically generated author record based on publicly available information.

Tsutomu Itagaki has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan

    by Katsumi Mizuta, Mika Saitoh, Miho Kobayashi, Hiroyuki Tsukagoshi, Yoko Aoki, Tatsuya Ikeda, Chieko Abiko, Noriko Katsushima, Tsutomu Itagaki, Masahiro Noda, et al.

    Background: Human parainfluenza virus type 1 (HPIV1) causes various acute respiratory infections (ARI). Hemagglutinin-neuraminidase (HN) glycoprotein of HPIV1 is a major antigen. However, the molecular epidemiology and genetic characteristics of such ARI are not exactly known. Recent studies suggested that a phylogenetic analysis tool, namely the maximum likelihood (ML) method, may be applied to estimate the evolutionary time scale of various viruses. Thus, we conducted detailed genetic analyses including homology analysis, phylogenetic analysis (using both the neighbor joining (NJ) and ML methods), and analysis of the pairwise distances ofHNgene in HPIV1 isolated from patients with ARI in Yamagata prefecture, Japan.Results: A few substitutions of nucleotides in the second binding site ofHNgene were observed among the present isolates. The strains were classified into two major clusters in the phylogenetic tree by the NJ method. Another phylogenetic tree constructed by the ML method showed that the strains diversified in the late 1980s. No positively selected sites were found in the present strains. Moreover, the pairwise distance among the present isolates was relatively short.Conclusions: The evolution ofHNgene in the present HPIV1 isolates was relatively slow. The ML method may be a useful phylogenetic method to estimate the evolutionary time scale of HPIV and other viruses.


  • Open Access

    Comparison of virus isolation using the Vero E6 cell line with real-time RT-PCR assay for the detection of human metapneumovirus

    by Yoko Matsuzaki, Katsumi Mizuta, Emi Takashita, Michiko Okamoto, Tsutomu Itagaki, Fumio Katsushima, Yuriko Katsushima, Yukio Nagai, Hidekazu Nishimura

    Background: The use of cell culture for the diagnosis of human metapneumovirus (hMPV) infection is uncommon at present and molecular method such as reverse-transcription PCR (RT-PCR) has been widely and most commonly used as the preferred test. We aimed to compare the results of virus isolation using Vero E6 cells with real-time RT-PCR for the detection of hMPV, since such a comparison data is not available.Methods: Between December 2007 and July 2008, we obtained 224 nasopharyngeal swab specimens from patients with acute respiratory infection and tested by the two methods.Results: Forty-three (19.2%) were found positive by cell culture and 62 (27.7%) by real-time RT-PCR. Cell cultures were positive for 42 of 62 specimens found positive by real-time RT-PCR (67.7% sensitivity) and for 1 of 162 specimens found negative by real-time RT-PCR (99.4% specificity), respectively. The sensitivity of the cell culture was 76.2-87.5% (mean 81.8%) when specimens were collected within 3 days after the onset of symptoms, and the sensitivity decreased to 50% or less thereafter. Among specimens collected within 3 days after symptom onset, all of the real-time RT-PCR positive specimens having a viral load of more than 1.25×105copies/ml were found positive by cell culture.Conclusions: Cell culture using Vero E6 cell line has 81.8% sensitivity compared with the real-time RT-PCR method, when specimens are collected within 3 days after the onset of symptoms. Thus, this method is a useful method for epidemiological and virological research even in facilities with minimal laboratory resources.


  • Open Access

    A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

    by Yoko Matsuzaki, Katsumi Mizuta, Yoko Aoki, Asuka Suto, Chieko Abiko, Kanako Sanjoh, Kanetsu Sugawara, Emi Takashita, Tsutomu Itagaki, Yuriko Katsushima, et al.

    Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resistant A(H1N1) viruses have circulated worldwide since the 2007-2008 influenza season. We aimed to determine the rate of oseltamivir resistance among A(H1N1) isolates from Yamagata, Japan, to compare the virological characteristics between isolates from the 2007-2008 and 2008-2009 seasons, and to evaluate the clinical effectiveness of oseltamivir.


  • Stability of the seven hexon hypervariable region sequences of adenovirus types 1–6 isolated in Yamagata, Japan between 1988 and 2007

    by Katsumi Mizuta, Yoko Matsuzaki, Seiji Hongo, Akira Ohmi, Michiko Okamoto, Hidekazu Nishimura, Tsutomu Itagaki, Noriko Katsushima, Hitoshi Oshitani, Akira Suzuki, et al.